These findings indicate that SS-b2 effectively suppresses the proliferation of MCF-7 breast cancer cells by inhibiting the activation of STAT3 and reducing the expression levels of VASP, MMP2, and MMP9. The gene discussed is VASP; the disease is breast carcinoma.